OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin
Ronen Sadeh, Israa Sharkia, Gavriel Fialkoff, et al.
Nature Biotechnology (2021) Vol. 39, Iss. 5, pp. 586-598
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
Asaf Zviran, Rafael Schulman, Minita Shah, et al.
Nature Medicine (2020) Vol. 26, Iss. 7, pp. 1114-1124
Open Access | Times Cited: 290

Inferring gene expression from cell-free DNA fragmentation profiles
Mohammad Shahrokh Esfahani, Emily G. Hamilton, Mahya Mehrmohamadi, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 4, pp. 585-597
Open Access | Times Cited: 124

A clinician’s handbook for using ctDNA throughout the patient journey
Samantha O. Hasenleithner, Michael R. Speicher
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 80

Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies
Carmen Martin-Alonso, Shervin Tabrizi, Kan Xiong, et al.
Science (2024) Vol. 383, Iss. 6680
Open Access | Times Cited: 58

Bridging biological cfDNA features and machine learning approaches
Tina Moser, Stefan Kühberger, Isaac Lazzeri, et al.
Trends in Genetics (2023) Vol. 39, Iss. 4, pp. 285-307
Open Access | Times Cited: 56

Drug-tolerant persister cells in cancer: the cutting edges and future directions
Yi Pu, Lu Li, Haoning Peng, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 799-813
Closed Access | Times Cited: 50

Liquid biopsy epigenomic profiling for cancer subtyping
Sylvan C. Baca, Ji-Heui Seo, Matthew P. Davidsohn, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2737-2741
Open Access | Times Cited: 42

Liquid Biopsy Based on Cell-Free DNA and RNA
Conor J. Loy, Lauren S. Ahmann, Iwijn De Vlaminck, et al.
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 169-195
Closed Access | Times Cited: 13

Cell types of origin of the cell-free transcriptome
Sevahn K. Vorperian, Mira N. Moufarrej, Robert C. Jones, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 6, pp. 855-861
Open Access | Times Cited: 64

Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics
Vadim Fedyuk, Nir Erez, Noa Furth, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 2, pp. 212-221
Open Access | Times Cited: 49

Liquid biopsy reveals collateral tissue damage in cancer
Asael Lubotzky, Hai Zemmour, Daniel Neiman, et al.
JCI Insight (2022) Vol. 7, Iss. 2
Open Access | Times Cited: 41

Treating inflammation to combat non-alcoholic fatty liver disease
Leke Wiering, Frank Tacke
Journal of Endocrinology (2022) Vol. 256, Iss. 1
Open Access | Times Cited: 41

New Perspectives on the Importance of Cell-Free DNA Biology
Abel J. Bronkhorst, Vida Ungerer, Angela Oberhofer, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2147-2147
Open Access | Times Cited: 39

Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs
Ze Zhou, L. Mary‐Jane, Rebecca W. Y. Chan, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 17
Open Access | Times Cited: 33

Cell-Free DNA Fragmentomics: The Novel Promising Biomarker
Ting Qi, Min Pan, Huajuan Shi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1503-1503
Open Access | Times Cited: 32

Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes
Ori Fridlich, Ayelet Peretz, Ilana Fox-Fisher, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 6, pp. 101074-101074
Open Access | Times Cited: 23

Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review
Gianna Di Sario, Valeria Rossella, Elvira Smeralda Famulari, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 21

Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications
Danielle Benedict Sacdalan, Sami Ul Haq, Benjamin H. Lok
Current Oncology (2024) Vol. 31, Iss. 1, pp. 482-500
Open Access | Times Cited: 6

Multiplexed Bio‐detection on an Interferometric Optical Waveguide Assembly
Oleksii Bratash, Rémi Courson, Laurent Malaquin, et al.
Advanced Materials Interfaces (2025)
Open Access

Artificial intelligence and machine learning in cell-free-DNA-based diagnostics
WY Tsui, Spencer C. Ding, Peiyong Jiang, et al.
Genome Research (2025) Vol. 35, Iss. 1, pp. 1-19
Closed Access

Cell‐free epigenomes enhanced fragmentomics‐based model for early detection of lung cancer
Yadong Wang, Qiang Guo, Zhicheng Huang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access

At the dawn: cell-free DNA fragmentomics and gene regulation
Yaping Liu
British Journal of Cancer (2021) Vol. 126, Iss. 3, pp. 379-390
Open Access | Times Cited: 52

Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer
Aitor Rodríguez‐Casanova, Nicolás Costa‐Fraga, Aida Bao‐Caamano, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 39

Remote immune processes revealed by immune-derived circulating cell-free DNA
Ilana Fox-Fisher, Sheina Piyanzin, Bracha Lea Ochana, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 39

Page 1 - Next Page

Scroll to top